International Clinical Trial: Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO2-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07361861) titled 'Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO2-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60' on Jan. 21.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: University of Texas at Austin

Condition: Cardiovascular Fitness Inflammation

Intervention: Device: Hyperbaric Oxygen Therapy

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: January 2026

Target Sample Size: 30

Countries of Recruitment: United States

To know more, visit https://c...